Tsunedomi相关文献与解析，生知库 | 链接生命科学的每一步

Ando, Sana; Ikeda, Shunta; Tanaka, Keiko; Tomabechi, Yuri; Yamagata, Atsushi; Shirouzu, Mikako; Tsunedomi, Ryouichi; Nagano, Hiroaki; Tsuji, Shunya; Sato, Koichi; Ohama, Takashi

蛋白降解

发表日期：2026

文献求助收藏

Refining Outcomes in Technically Resectable Colorectal Liver Metastases: A Simplified Risk Model and the Role of Preoperative Chemotherapy

改善技术上可切除的结直肠肝转移瘤的治疗效果：简化的风险模型和术前化疗的作用

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers18020227

Kanesada, Kou; Nakajima, Masao; Ioka, Tatsuya; Tomochika, Shinobu; Shindo, Yoshitaro; Tokumitsu, Yukio; Matsui, Hiroto; Tanaka, Hironori; Nakagami, Yuki; Tsunedomi, Ryouichi; Iida, Michihisa; Takahashi, Hidenori; Nagano, Hiroaki

发表日期：2026

文献求助收藏

The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer

C11orf24基因作为预测改良FOLFIRINOX方案治疗胰腺癌后严重中性粒细胞减少症的有效生物标志物

期刊:Cancer Science

影响因子:4.3

doi:10.1111/cas.70087

Kanesada, Gen; Tsunedomi, Ryouichi; Nakagami, Yuki; Matsui, Hiroto; Shindo, Yoshitaro; Tomochika, Shinobu; Akita, Hirofumi; Ioka, Tatsuya; Takahashi, Hidenori; Nagano, Hiroaki

Novel immune drug combination induces tumour microenvironment remodelling and reduces the dosage of anti-PD-1 antibody

新型免疫药物组合可诱导肿瘤微环境重塑并降低抗PD-1抗体的剂量

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-87344-6

Ozasa, Takahiro; Nakajima, Masao; Tsunedomi, Ryouichi; Goto, Shunsuke; Adachi, Keishi; Takahashi, Hidenori; Tamada, Koji; Nagano, Hiroaki

Novel organoid-based exploration reveals the role of LMTK3/FADS2 signaling in metastatic breast cancer progression in felines and humans.

基于类器官的新型探索揭示了 LMTK3/FADS2 信号在猫和人类转移性乳腺癌进展中的作用。

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-28751-7

Yamamoto Haru, Elbadawy Mohamed, Tsunedomi Ryouichi, Maeda Noriko, Nagano Hiroaki, Ishihara Yusuke, Abugomaa Amira, Shiota Yomogi, Yu Ting-Wei, Liu Yishan, Nagashima Yuko, Kobayashi Yuki, Matsui Riho, Uomoto Suzuka, Kobayashi Mio, Yoshida Toshinori, Shibutani Makoto, Kobayashi Tetsuya, Inoue Mai, Higashinaka Midori, Fukushima Ryuji, Azakami Daigo, Uchide Tsuyoshi, Shinohara Yuta, Yamawaki Hideyuki, Kaneda Masahiro, Usui Tatsuya, Sasaki Kazuaki

A Case of Inflammatory Myofibroblastic Tumor in the Abdominal Wall with Anaplastic Lymphoma Kinase and Whole Exome Sequencing Analysis

一例伴有间变性淋巴瘤激酶表达的腹壁炎性肌纤维母细胞瘤及全外显子组测序分析

期刊:Surgical Case Reports

影响因子:0.7

doi:10.70352/scrj.cr.25-0181.

Yuya Takahata,Shoichi Hazama,Toshiyuki Fujii,Masahiro Kitahara,Keisuke Hino,Kiwamu Okita,Hiroaki Nagano,Ryouichi Tsunedomi,Hiroshi Hashiyada,Kembu Nakamoto

Protein phosphatase 6 promotes stemness of colorectal cancer cells

蛋白磷酸酶 6 促进结直肠癌细胞的干细胞化

期刊:Cancer Science

影响因子:4.5

doi:10.1111/cas.16271

Nobuyuki Fujiwara, Ryouichi Tsunedomi, Yuta Kimura, Masao Nakajima, Shinobu Tomochika, Shuhei Enjoji, Takashi Ohama, Koichi Sato, Hiroaki Nagano

High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancer

血清蛋白酶 3 水平高预示转移性结直肠癌无进展生存期较差且贝伐单抗疗效较低

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-024-11924-4

Kei Furuya, Masao Nakajima, Ryouichi Tsunedomi, Yuki Nakagami, Ming Xu, Hiroto Matsui, Yukio Tokumitsu, Yoshitaro Shindo, Yusaku Watanabe, Shinobu Tomochika, Noriko Maeda, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Shoichi Hazama, Tatsuya Ioka, Yoshinobu Hoshii, Tomio Ueno, Hiroaki Nagano

Phase I study of a novel therapeutic vaccine as perioperative treatment for patients with surgically resectable hepatocellular carcinoma: The YCP02 trial

新型治疗性疫苗作为可手术切除的肝细胞癌患者围手术期治疗的 I 期研究：YCP02 试验

期刊:Hepatology Research

影响因子:3.9

doi:10.1111/hepr.13900

Masao Nakajima, Shoichi Hazama, Yukio Tokumitsu, Yoshitaro Shindo, Hiroto Matsui, Satoshi Matsukuma, Yuki Nakagami, Koji Tamada, Keiko Udaka, Michiie Sakamoto, Akira Saito, Yasunari Kouki, Toshinari Uematsu, Ming Xu, Michihisa Iida, Ryouichi Tsunedomi, Nobuaki Suzuki, Shigeru Takeda, Tatsuya Ioka, S

Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity

R3HCC1基因单核苷酸多态性与伊立替康毒性之间的关联

期刊:Cancer Medicine

影响因子:3.1

doi:10.1002/cam4.5299

Kanesada, Kou; Tsunedomi, Ryouichi; Hazama, Shoichi; Ogihara, Hiroyuki; Hamamoto, Yoshihiko; Shindo, Yoshitaro; Matsui, Hiroto; Tokumitsu, Yukio; Yoshida, Shin; Iida, Michihisa; Suzuki, Nobuaki; Takeda, Shigeru; Ioka, Tatsuya; Nagano, Hiroaki

毒理研究

发表日期：2023

文献求助收藏

Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels

c-Myc蛋白降解途径的切换取决于PP2A-B55α复合物的水平

Refining Outcomes in Technically Resectable Colorectal Liver Metastases: A Simplified Risk Model and the Role of Preoperative Chemotherapy

改善技术上可切除的结直肠肝转移瘤的治疗效果：简化的风险模型和术前化疗的作用

The C11orf24 Gene as a Useful Biomarker for Predicting Severe Neutropenia in Modified FOLFIRINOX for Pancreatic Cancer

C11orf24基因作为预测改良FOLFIRINOX方案治疗胰腺癌后严重中性粒细胞减少症的有效生物标志物

Novel immune drug combination induces tumour microenvironment remodelling and reduces the dosage of anti-PD-1 antibody

新型免疫药物组合可诱导肿瘤微环境重塑并降低抗PD-1抗体的剂量

Novel organoid-based exploration reveals the role of LMTK3/FADS2 signaling in metastatic breast cancer progression in felines and humans.

基于类器官的新型探索揭示了 LMTK3/FADS2 信号在猫和人类转移性乳腺癌进展中的作用。

A Case of Inflammatory Myofibroblastic Tumor in the Abdominal Wall with Anaplastic Lymphoma Kinase and Whole Exome Sequencing Analysis

一例伴有间变性淋巴瘤激酶表达的腹壁炎性肌纤维母细胞瘤及全外显子组测序分析

Protein phosphatase 6 promotes stemness of colorectal cancer cells

蛋白磷酸酶 6 促进结直肠癌细胞的干细胞化

High serum proteinase-3 levels predict poor progression-free survival and lower efficacy of bevacizumab in metastatic colorectal cancer

血清蛋白酶 3 水平高预示转移性结直肠癌无进展生存期较差且贝伐单抗疗效较低

Phase I study of a novel therapeutic vaccine as perioperative treatment for patients with surgically resectable hepatocellular carcinoma: The YCP02 trial

新型治疗性疫苗作为可手术切除的肝细胞癌患者围手术期治疗的 I 期研究：YCP02 试验

Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity

R3HCC1基因单核苷酸多态性与伊立替康毒性之间的关联